Concepts (161)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Arthritis, Infectious | 2 | 2018 | 111 | 1.25 | Why? |
| Osteomyelitis | 2 | 2018 | 131 | 1.22 | Why? |
| Bronchiolitis, Viral | 3 | 2020 | 71 | 1.14 | Why? |
| Coronary Aneurysm | 2 | 2018 | 132 | 0.77 | Why? |
| Sclerotherapy | 1 | 2018 | 23 | 0.72 | Why? |
| Parotitis | 1 | 2018 | 38 | 0.71 | Why? |
| Vascular Malformations | 1 | 2018 | 52 | 0.69 | Why? |
| Human bocavirus | 1 | 2018 | 142 | 0.68 | Why? |
| Bleomycin | 1 | 2018 | 195 | 0.65 | Why? |
| Parvoviridae Infections | 1 | 2018 | 222 | 0.62 | Why? |
| Fever of Unknown Origin | 1 | 2017 | 93 | 0.61 | Why? |
| Compassionate Use Trials | 1 | 2020 | 632 | 0.61 | Why? |
| Spain | 16 | 2021 | 15545 | 0.60 | Why? |
| Pediatrics | 2 | 2020 | 2969 | 0.52 | Why? |
| Mucocutaneous Lymph Node Syndrome | 3 | 2018 | 1645 | 0.46 | Why? |
| Infant | 20 | 2021 | 30274 | 0.39 | Why? |
| Acute Lung Injury | 1 | 2018 | 904 | 0.38 | Why? |
| Patient Care Management | 1 | 2020 | 1514 | 0.36 | Why? |
| Child, Preschool | 15 | 2021 | 36283 | 0.33 | Why? |
| Child | 20 | 2021 | 70012 | 0.33 | Why? |
| Adenosine Monophosphate | 2 | 2021 | 5652 | 0.31 | Why? |
| Alanine | 2 | 2021 | 5687 | 0.31 | Why? |
| Rheumatic Diseases | 1 | 2021 | 2675 | 0.28 | Why? |
| Immunocompromised Host | 1 | 2020 | 5150 | 0.26 | Why? |
| Picornaviridae Infections | 2 | 2020 | 544 | 0.25 | Why? |
| Immunosuppressive Agents | 1 | 2020 | 6331 | 0.23 | Why? |
| Mucopolysaccharidosis I | 1 | 2020 | 9 | 0.22 | Why? |
| Pneumonia | 1 | 2021 | 5652 | 0.21 | Why? |
| Synovitis | 1 | 2019 | 47 | 0.19 | Why? |
| Anti-Bacterial Agents | 2 | 2018 | 10083 | 0.19 | Why? |
| Injections, Intralesional | 1 | 2018 | 34 | 0.18 | Why? |
| Hospitalization | 7 | 2020 | 54280 | 0.17 | Why? |
| Biomedical Research | 1 | 2018 | 5270 | 0.17 | Why? |
| Respiratory Tract Infections | 4 | 2020 | 6817 | 0.17 | Why? |
| Respiratory Sounds | 1 | 2020 | 294 | 0.17 | Why? |
| Parechovirus | 1 | 2017 | 48 | 0.17 | Why? |
| Child, Hospitalized | 1 | 2021 | 556 | 0.17 | Why? |
| Bradycardia | 1 | 2021 | 292 | 0.16 | Why? |
| Sulfides | 1 | 2018 | 113 | 0.16 | Why? |
| Enterovirus A, Human | 1 | 2019 | 180 | 0.16 | Why? |
| Arthritis, Juvenile | 1 | 2019 | 191 | 0.16 | Why? |
| Acetates | 1 | 2018 | 123 | 0.16 | Why? |
| Interleukin-33 | 1 | 2017 | 120 | 0.15 | Why? |
| Coated Materials, Biocompatible | 1 | 2017 | 113 | 0.15 | Why? |
| Adrenomedullin | 1 | 2018 | 217 | 0.15 | Why? |
| Cyclopropanes | 1 | 2018 | 332 | 0.15 | Why? |
| Infant, Newborn | 8 | 2021 | 23105 | 0.15 | Why? |
| Titanium | 1 | 2017 | 175 | 0.14 | Why? |
| Humans | 35 | 2021 | 930598 | 0.14 | Why? |
| Disease Outbreaks | 2 | 2020 | 27595 | 0.14 | Why? |
| Male | 21 | 2021 | 367725 | 0.14 | Why? |
| Coronavirus NL63, Human | 1 | 2020 | 669 | 0.14 | Why? |
| Rhinovirus | 1 | 2020 | 979 | 0.14 | Why? |
| Metapneumovirus | 1 | 2017 | 465 | 0.13 | Why? |
| Administration, Intravenous | 1 | 2018 | 1115 | 0.13 | Why? |
| Enterovirus Infections | 1 | 2019 | 404 | 0.13 | Why? |
| Cell Adhesion Molecules | 1 | 2017 | 472 | 0.13 | Why? |
| Bronchiolitis | 1 | 2018 | 297 | 0.13 | Why? |
| Female | 20 | 2021 | 380317 | 0.13 | Why? |
| Quinolines | 1 | 2018 | 403 | 0.13 | Why? |
| Prospective Studies | 9 | 2021 | 43301 | 0.12 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.12 | Why? |
| Polyethylene Glycols | 1 | 2017 | 574 | 0.12 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.12 | Why? |
| Coronavirus OC43, Human | 1 | 2020 | 1157 | 0.12 | Why? |
| Adolescent | 9 | 2021 | 86841 | 0.11 | Why? |
| Severity of Illness Index | 6 | 2021 | 48226 | 0.11 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.11 | Why? |
| Administration, Oral | 1 | 2018 | 2340 | 0.11 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2020 | 1234 | 0.11 | Why? |
| Age Distribution | 1 | 2020 | 3567 | 0.10 | Why? |
| Critical Illness | 4 | 2021 | 17281 | 0.09 | Why? |
| Hospitals, University | 1 | 2021 | 4173 | 0.09 | Why? |
| Prognosis | 3 | 2020 | 32490 | 0.09 | Why? |
| Treatment Outcome | 3 | 2020 | 51732 | 0.09 | Why? |
| Seasons | 1 | 2020 | 4071 | 0.08 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.08 | Why? |
| Methylprednisolone | 1 | 2018 | 2107 | 0.08 | Why? |
| Fever | 2 | 2021 | 7795 | 0.08 | Why? |
| Tertiary Care Centers | 2 | 2021 | 8248 | 0.08 | Why? |
| Retrospective Studies | 5 | 2020 | 105322 | 0.07 | Why? |
| Hypoxia | 1 | 2020 | 3626 | 0.07 | Why? |
| Viruses | 1 | 2019 | 2238 | 0.07 | Why? |
| Drug Therapy, Combination | 1 | 2018 | 7268 | 0.07 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.07 | Why? |
| Follow-Up Studies | 2 | 2021 | 17020 | 0.06 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.06 | Why? |
| Ambulatory Care | 1 | 2020 | 4947 | 0.06 | Why? |
| Ultrasonography | 1 | 2019 | 4409 | 0.06 | Why? |
| Disease Progression | 2 | 2019 | 13580 | 0.06 | Why? |
| Virus Diseases | 1 | 2019 | 3779 | 0.05 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 6653 | 0.05 | Why? |
| Nervous System Diseases | 1 | 2019 | 4092 | 0.05 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.05 | Why? |
| Sepsis | 1 | 2017 | 3517 | 0.05 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.05 | Why? |
| Synovial Membrane | 1 | 2019 | 72 | 0.05 | Why? |
| Asthma | 1 | 2017 | 4383 | 0.05 | Why? |
| Thrombosis | 1 | 2021 | 7504 | 0.05 | Why? |
| Heart Failure | 1 | 2020 | 6638 | 0.05 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2020 | 8843 | 0.05 | Why? |
| Streptococcus sanguis | 1 | 2017 | 2 | 0.04 | Why? |
| Lactobacillus salivarius | 1 | 2017 | 2 | 0.04 | Why? |
| Nasopharynx | 1 | 2017 | 10224 | 0.04 | Why? |
| Bacterial Adhesion | 1 | 2017 | 69 | 0.04 | Why? |
| Risk Factors | 3 | 2021 | 71621 | 0.04 | Why? |
| Risk Assessment | 2 | 2018 | 25439 | 0.04 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Cell Adhesion | 1 | 2017 | 230 | 0.04 | Why? |
| Dental Implants | 1 | 2017 | 101 | 0.04 | Why? |
| Influenza, Human | 1 | 2020 | 10779 | 0.04 | Why? |
| Surface Properties | 1 | 2017 | 448 | 0.04 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.04 | Why? |
| Remission Induction | 1 | 2019 | 950 | 0.04 | Why? |
| Methotrexate | 1 | 2019 | 471 | 0.04 | Why? |
| Cytokines | 1 | 2017 | 15010 | 0.04 | Why? |
| Phylogeography | 1 | 2019 | 824 | 0.03 | Why? |
| RNA, Viral | 2 | 2021 | 32276 | 0.03 | Why? |
| Biofilms | 1 | 2017 | 304 | 0.03 | Why? |
| Molecular Epidemiology | 1 | 2019 | 1638 | 0.03 | Why? |
| Hospitals, Urban | 1 | 2018 | 950 | 0.03 | Why? |
| Fibroblasts | 1 | 2017 | 839 | 0.03 | Why? |
| Bayes Theorem | 1 | 2021 | 3237 | 0.03 | Why? |
| Cross-Sectional Studies | 4 | 2021 | 53120 | 0.03 | Why? |
| Seroconversion | 1 | 2021 | 2515 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2018 | 25144 | 0.03 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.03 | Why? |
| Fatal Outcome | 1 | 2020 | 3438 | 0.03 | Why? |
| Interleukin-10 | 1 | 2017 | 1409 | 0.03 | Why? |
| Sequence Analysis, DNA | 1 | 2019 | 2830 | 0.03 | Why? |
| Intensive Care Units, Pediatric | 1 | 2017 | 1098 | 0.02 | Why? |
| Sequence Analysis, RNA | 1 | 2019 | 2290 | 0.02 | Why? |
| Recurrence | 1 | 2019 | 3675 | 0.02 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2019 | 2483 | 0.02 | Why? |
| Hospitals, Pediatric | 1 | 2018 | 1792 | 0.02 | Why? |
| Interferon-gamma | 1 | 2017 | 2711 | 0.02 | Why? |
| Shock, Septic | 1 | 2017 | 1313 | 0.02 | Why? |
| Family | 1 | 2021 | 2909 | 0.02 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 3633 | 0.02 | Why? |
| Incidence | 2 | 2018 | 25622 | 0.02 | Why? |
| Comorbidity | 2 | 2021 | 34796 | 0.02 | Why? |
| Biological Products | 1 | 2019 | 2331 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2017 | 6740 | 0.01 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.01 | Why? |
| Antigens, Viral | 1 | 2019 | 6298 | 0.01 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.01 | Why? |
| Phylogeny | 1 | 2019 | 13341 | 0.01 | Why? |
| Prevalence | 1 | 2021 | 25773 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2019 | 13720 | 0.01 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2021 | 9706 | 0.01 | Why? |
| Disease Transmission, Infectious | 1 | 2021 | 9044 | 0.01 | Why? |
| Critical Care | 1 | 2021 | 14081 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
| Genome, Viral | 1 | 2019 | 13157 | 0.01 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.01 | Why? |
| Time Factors | 1 | 2017 | 31397 | 0.01 | Why? |
| Hospital Mortality | 1 | 2017 | 22087 | 0.01 | Why? |
| Young Adult | 1 | 2021 | 93724 | 0.01 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.01 | Why? |
| Adult | 1 | 2021 | 244371 | 0.00 | Why? |
Calvo's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(161)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(150)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_